Skip to main content
Log in

Understanding Bartter syndrome and Gitelman syndrome

  • Review Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

We aim to review the clinical features of two renal tubular disorders characterized by sodium and potassium wasting: Bartter syndrome and Gitelman syndrome.

Data sources

Selected key references concerning these syndromes were analyzed, together with a PubMed search of the literature from 2000 to 2011.

Results

The clinical features common to both conditions and those which are distinct to each syndrome were presented. The new findings on the genetics of the five types of Bartter syndrome and the discrete mutations in Gitelman syndrome were reviewed, together with the diagnostic workup and treatment for each condition.

Conclusions

Patients with Bartter syndrome types 1, 2 and 4 present at a younger age than classic Bartter syndrome type 3. They present with sypmtoms, often quite severe in the neonatal period. Patients with classic Bartter syndrome type 3 present later in life and may be sporadically asymptomatic or mildly symptomatic. The severe, steady-state hypokalemia in Bartter syndrome and Gitelman syndrome may abruptly become lifethreatening under certain aggravating conditions. Clinicians need to be cognizant of such renal tubular disorders, and promptly treat at-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962;33:811–828.

    Article  PubMed  CAS  Google Scholar 

  2. Gill JR Jr, Bartter FC. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter’s syndrome. Am J Med 1978;65:766–772.

    Article  PubMed  CAS  Google Scholar 

  3. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966;79:221–235.

    PubMed  CAS  Google Scholar 

  4. Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008;4:560–567.

    Article  PubMed  Google Scholar 

  5. Chan JC, Gill JR Jr, Bartter FC. Lack of evidence for a role of prostaglandin in the mediation of impaired urinary concentrating ability in Bartter’s syndrome. Nephron 1983;35:116–119.

    Article  PubMed  CAS  Google Scholar 

  6. Roth KS, Ward RJ, Chan JCM, Sarafoglou K. Disorders of calcium, phosphate, and bone metabolism. In: Sarafoglou K, Hoffmann GF, Roth KS, eds. Pediatric Endocrinology and Inborn Errors of Metabolism. New York: McGraw Hill Medical Publishers, 2009: 619–664.

    Google Scholar 

  7. Fukuyama S, Okudaira S, Yamazato S, Yamazato M, Ohta T. Analysis of renal tubular electrolyte transporter genes in seven patients with hypokalemic metabolic alkalosis. Kidney Int 2003;64:808–816.

    Article  PubMed  CAS  Google Scholar 

  8. Bailey MA, Cantone A, Yan Q, MacGregor GG, Leng Q, Amorim JB, et al. Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of type II Bartter’s syndrome and in an adaptation to a high K diet. Kidney Int 2006;70:51–59.

    Article  PubMed  CAS  Google Scholar 

  9. Kramer BK, Bergler T, Stoelcker B, Waldegger S. Mechanisms of disease. The kidney specific chloride channels ClCKA, ClCKB, the Barttin subunit, and their clinical relevance. Nat Clin Pract Nephrol 2008;4:38–46.

    Article  PubMed  Google Scholar 

  10. Jang HR, Lee JW, Oh YK. From bench to bedside. Diagnosis of Gitelman’s syndrome—defect of sodium-chloride cotransporter in renal tissue. Kidney Int 2006;70:813–817.

    Article  PubMed  CAS  Google Scholar 

  11. Colussi G, Bettinelli A, Tedesehi S. A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol 2007;2:454–460.

    Article  PubMed  CAS  Google Scholar 

  12. Sassen MC, Jeck N, Klaus G. Can renal tubular hypokalemic disorders be accurately diagnosed on the basis of the diuretic response to thiazide? Nat Clin Pract Nephrol 2007;3:528–529.

    Article  PubMed  Google Scholar 

  13. Mersin SS, Ramelli GP, Laux-End R, Bianchetti MG. Urinary chloride excretion distinguishes between renal and extrarenal metabolic alkalosis. Eur J Pediatr 1995;154:979–982.

    Article  PubMed  CAS  Google Scholar 

  14. Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F, et al; Italian Collaborative Group for Bartter Syndrome. Long-term follow-up of patients with Bartter syndrome type I and II. Nephrol Dial Transplant 2010;25:2976–2981.

    Article  PubMed  Google Scholar 

  15. Vaisbich MH, Fujimura MD, Koch VH. Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 2004;19:858–863.

    Article  PubMed  Google Scholar 

  16. Chan JCM. Potassium disturbances. In: Lai KN, eds. A Practical Manual of Renal Medicine. Singapore: World Scientific/Imperial College Press, 2009: 39–44.

    Chapter  Google Scholar 

  17. Trachtman H, Gipson D. Bartter and Gitelman syndromes. NephSAP 2009;8:50–51.

    Google Scholar 

  18. Gill JR Jr, Santos F, Chan JCM. Disorders of potassium metabolism. In: Chan JCM, Gill JR Jr, eds. Kidney Electrolyte Disorders. New York: Churchill Livingstone, 1990: 137–170.

    Google Scholar 

  19. Cortesi C, Lava SA, Bettinelli A, Tammaro F, Giannini O, Caiata-Zufferey M, et al. Cardiac arrhythmias and rhabdomyolysis in Bartter-Gitelman patients. Pediatr Nephrol 2010;25:2005–2008.

    Article  PubMed  Google Scholar 

  20. Bettinelli A, Borsa N, Syren ML. Simultaneous mutations in the ClCNKB and SLC12A3 genes in two siblings with phenotypic heterogeneity in classic Bartter syndrome. Pediatr Res 2005;58:1269–1273.

    Article  PubMed  CAS  Google Scholar 

  21. Cruz DN, Shafer AJ, Bia MJ, Lifton RP, Simon DB. Gitelman syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 2001;59:710–711.

    Article  PubMed  CAS  Google Scholar 

  22. Sabath E, Meade P, Beckman J. Pathophysiology of functional mutations of the thiazide-sensitive Na-K co-transporter in Gitelman disease. Am J Physiol 2004;287:F195–F203.

    Article  CAS  Google Scholar 

  23. Nozu K, Inagaki T, Fu XJ, Nozu Y, Kaito H, Kanda K, et al. Moelcular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness. J Med Genet 2008;45:182–186.

    Article  PubMed  CAS  Google Scholar 

  24. Simon DB, Karet FE, Hamdan JM, DiPetro A, Sanjad SA, Lifton RP. Bartter syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutation in the Na-K-2Cl trasporter NKCC2. Nat Genet 1996;13:183–188.

    Article  PubMed  CAS  Google Scholar 

  25. Su I, Frank R, Gauthier BG. Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 2000;14:970–972.

    Article  PubMed  CAS  Google Scholar 

  26. Leonhardt A, Timmermans G, Roth B, Seyberth HW. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr 1992;120:546–554.

    Article  PubMed  CAS  Google Scholar 

  27. Restrepo de Rovetto C, Welch TR, Hug G, Clark KE, Bergstrom W. Hypercalciuria and Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 1989;115:397–404.

    Article  PubMed  CAS  Google Scholar 

  28. Roth KS. Disorders of membrane transport. In: Sarafoglou K, Hoffmann GF, Roth KS, eds. Pediatric Endocrinology and Inborn Errors of Metabolism. New York: McGraw Hill Med Publishing, 2009: 693–717.

    Google Scholar 

  29. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hyeprtens 2003;12;527–532.

    Article  Google Scholar 

  30. Kleta R, Bockenhauer D. Bartter syndromes and other salt-losing tubulopathies. Nephron Physiol 2006;104:73–80.

    Article  Google Scholar 

  31. Abuladze N, Yanagawa N, Lee I. Peripheral blood mononuclear cells express mutated NCCT mRNA in Gitelman syndrome: evidence for abnormal thiazide-sensitive NaCl cotransport. J Am Soc Nephrol 1998;9:819–826.

    PubMed  CAS  Google Scholar 

  32. Yang SS, Lo YF, Wu CC. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 2010;21:1868–1877.

    Article  PubMed  CAS  Google Scholar 

  33. Rodan AR, Huang C. An emerging role for SPAK in NCC, NKCC, and blood pressure regulation. J Am Soc Nephrol 2010;21:1812–1814.

    Article  PubMed  Google Scholar 

  34. Kral A, O’Donoghue GM. Profound deafness in childhood. N Engl J Med 2010;363:1438–1450.

    Article  PubMed  CAS  Google Scholar 

  35. Ataoglu E, Civilibal M, Ozkul AA, Varal IG, Oktay ER, Murat E. Indomethacin-induced colon perforation in Bartter’s syndrome. Indian J Pediatr 2009;76:322–323.

    Article  PubMed  Google Scholar 

  36. Marlow N, Chiswick ML. Neonatal Bartter’s syndrome, indomethacin and necrotising enterocolitis. Acta Paediatr Scand 1982;71:1031–1032.

    Article  PubMed  CAS  Google Scholar 

  37. Luthy C, Bettinelli A, Iselin S, Metta MG, Basilico E, Oetliker OH, et al. Normal prostaglandinuria E2 in Gitelman’s syndrome, the hypocalciuric variant of Bartter’s syndrome. Am J Kidney Dis 1995;25:828–829.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James C. M. Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fremont, O.T., Chan, J.C.M. Understanding Bartter syndrome and Gitelman syndrome. World J Pediatr 8, 25–30 (2012). https://doi.org/10.1007/s12519-012-0333-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-012-0333-9

Key words

Navigation